Yüklüyor......
The Akt signaling pathway: An emerging therapeutic target in malignant melanoma
Studies using cultured melanoma cells and patient tumor biopsies have demonstrated deregulated PI3 kinase-Akt3 pathway activity in ∼70% of melanomas. Furthermore, targeting Akt3 and downstream PRAS40 has been shown to inhibit melanoma tumor development in mice. Although these preclinical studies and...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3335938/ https://ncbi.nlm.nih.gov/pubmed/22157148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.12.12.18442 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|